Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001214659-17-005551)

Filing Details

Accession Number:: 0001214659-17-005551
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-09-07 18:56:38
Reporting Period:: 2017-09-07

Accepted Time:: 2017-09-07 18:56:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1316175	Anthera Pharmaceuticals Inc	ANTH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1120362	F Paul Truex	25801 Industrial Blvd Suite B Hayward CA 94545		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-09-07	5,000	$1.34	16,793	No	4	P	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Trust

Footnotes

The Reporting Person acquired the shares in the open market and through the 2005 Truex Family Trust u/d/t April 20, 2005. Shares have been adjusted to reflect the issuer's 1-for-8 reverse stock split effectuated on April 28, 2017.